Macmirorcomplex

Nystatin and Nifuratel, the active ingredients in Macmirorcomplex, are an antifungal and an antiprotozoal presented as a vaginal dosage form for local administration. The combination targets common vaginal infections, specifically treating candidiasis, bacterial vaginosis and trichomoniasis in adult female patients.

GNH USA supplies Macmirorcomplex as a licensed, GDP‑compliant international pharmaceutical product, providing reliable bulk and packaged supplies to hospitals, pharmacies, transplant centres and oncology centres worldwide, adhering to EU quality standards and regulatory requirements. The company ensures timely shipment and comprehensive technical support.

Macmirorcomplex combines Nystatin and Nifuratel to act on fungal, bacterial and protozoal pathways in the vagina.

- Vaginal candidiasis: eradicates Candida species, relieving itching, discharge and irritation. - Bacterial vaginosis: reduces Gardnerella and other anaerobic bacteria, helping restore normal vaginal flora. - Trichomoniasis: eliminates Trichomonas vaginalis, alleviating malodorous discharge and discomfort.

Macmirorcomplex may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Vaginal irritation or burning: mild discomfort at the application site. - Itching or pruritus: transient sensation of itchiness. - Abnormal vaginal discharge: temporary change in discharge consistency or color. - Vulvar erythema: mild redness of the external genitalia. - Mild gastrointestinal upset: occasional nausea or abdominal discomfort. - Local allergic reaction: limited rash or swelling.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic response requiring immediate medical attention. - Severe vaginal ulceration: extensive tissue damage or ulcer formation. - Systemic fungal infection: rare dissemination of fungal organisms. - Hepatotoxicity: abnormal liver function tests in susceptible individuals.

Before using Macmirorcomplex, consider the following precautions.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Known hypersensitivity: avoid if allergic to Nystatin, Nifuratel, or formulation excipients. - Concurrent vaginal products: do not use other intravaginal medications within two hours of application. - Complete therapy: finish the prescribed course even if symptoms improve. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Macmirorcomplex may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Systemic azole antifungals: concurrent use may increase toxicity. - Intravaginal antiseptics or spermicides: may reduce therapeutic effectiveness.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics: can alter vaginal flora and affect drug performance. - Topical corticosteroids: may mask local irritation or inflammation. - Immunosuppressive agents: heightened risk of opportunistic infections.